Zentalis Pharmaceuticals Inc (ZNTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 33,901 | 41,320 | 36,976 | 37,616 | 28,038 |
| Marketable Securities | 337,183 | 349,932 | 389,409 | 451,368 | 454,881 |
| Receivables | 5,000 | N/A | N/A | N/A | N/A |
| TOTAL | $386,066 | $400,270 | $439,616 | $503,806 | $496,718 |
| Non-Current Assets | |||||
| PPE Net | 4,699 | 5,016 | 5,337 | 5,679 | 5,819 |
| Intangibles | 0 | 3,736 | 3,736 | 3,736 | 3,736 |
| Other Non-Current Assets | 39,572 | 41,639 | 42,991 | 44,258 | 45,415 |
| TOTAL | $44,271 | $50,391 | $52,064 | $53,673 | $54,970 |
| Total Assets | $430,337 | $450,661 | $491,680 | $557,479 | $551,688 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,438 | 8,202 | 20,440 | 10,502 | 14,926 |
| Accrued Expenses | 45,287 | 46,675 | 46,252 | 44,296 | 54,441 |
| TOTAL | $52,725 | $54,877 | $66,692 | $54,798 | $69,367 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40,426 | 41,453 | 42,407 | 43,938 | 44,952 |
| TOTAL | $40,426 | $41,453 | $42,407 | $43,910 | $44,930 |
| Total Liabilities | $93,151 | $96,330 | $109,099 | $98,708 | $114,297 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,812 | 71,265 | 71,108 | 71,013 | 70,960 |
| Common Shares | 71 | 71 | 71 | 70 | 70 |
| Retained earnings | -1,054,395 | -1,006,923 | -966,765 | -878,488 | -888,556 |
| Other shareholders' equity | 558 | 1,594 | 140 | 773 | 2,301 |
| TOTAL | $337,186 | $354,331 | $382,581 | $458,771 | $437,391 |
| Total Liabilities And Equity | $430,337 | $450,661 | $491,680 | $557,479 | $551,688 |